Uterine Cervical Neoplasms

Displaying 1 - 25 of 25CSV
Einbond, L. S., Zhou, J., Huang, K., Castellanos, M. R., Mbazor, E., Balick, M., Ma, H., DeVoti, J. A., Redenti, S., & Wu, H. (2024). Plant Compounds Inhibit the Growth of W12 Cervical Precancer Cells Containing Episomal or Integrant HPV DNA; Tanshinone IIA Synergizes with Curcumin in Cervical Cancer Cells. Viruses, 17(1), 55. https://doi.org/10.3390/v17010055
Publication Date
Diggs, A., Huang, Y., Melamed, A., Szamreta, E., Monberg, M. J., Hershman, D., & Wright, J. D. (2024). Patterns of use of primary and first-line chemotherapy for recurrence among patients with cervical cancer. International Journal of Gynecologic Cancer, 34(7), 1001–1010. https://doi.org/10.1136/ijgc-2023-004860
Publication Date
Agudelo, M. C., Torres-González, E., Agudelo, S., Ramírez, A. T., Castañeda, K. M., Kinslow, C. J., Rodríguez-Herrera, M., Garland, L., Xie, Y., Orozco, C. A., Stoler, M., Dean, M., & Sánchez, G. I. (2024). Comparación de las pruebas para el virus del papiloma humano Hybribio-H13 y Hybrid Capture® 2 para la detección de NIC2+ y NIC3+. Biomédica, 44(Sp. 1), 101–109. https://doi.org/10.7705/biomedica.7061
Publication Date
Lewis, A. G. C., Hernandez, D. M., Garcés-Palacio, I. C., & Soliman, A. S. (2024). Impact of the universal health insurance benefits on cervical cancer mortality in Colombia. BMC Health Services Research, 24(1). https://doi.org/10.1186/s12913-024-10979-0
Publication Date
Dinicu, A. I., Dioun, S., Wang, Y., Huang, Y., Wright, J. D., & Tergas, A. I. (2024). Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care. Gynecologic Oncology, 184, 214–223. https://doi.org/10.1016/j.ygyno.2024.01.043
Publication Date
Hsieh, K., Bloom, J. R., Dickstein, D. R., Hsieh, C., Marshall, D., Ghiassi-Nejad, Z., Raince, J., Lymberis, S., Chadha, M., & Gupta, V. (2024). Dose and fractionation regimen for brachytherapy boost in cervical cancer in the US. Gynecologic Oncology, 180, 55–62. https://doi.org/10.1016/j.ygyno.2023.11.014
Publication Date
Denny, L., Saidu, R., Boa, R., Mbatani, N., Castor, D., Moodley, J., & Kuhn, L. (2023). Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-43467-2
Publication Date
Dinicu, A. I., Dioun, S., Goldberg, M., Crookes, D. M., Wang, Y., & Tergas, A. I. (2023). Region of origin and cervical cancer stage in multiethnic Hispanic/Latinx patients living in the United States. Cancer Medicine, 12(23), 21452–21464. Portico. https://doi.org/10.1002/cam4.6697
Publication Date
Connelly, C. F., Collins, N., Cimic, A., & Baskota, S. U. (2023). Significance of concurrent HPV testing with unsatisfactory Papanicolaou test for prediction of follow-up HPV, Papanicolaou test, and biopsy results. American Journal of Clinical Pathology, 160(5), 444–449. https://doi.org/10.1093/ajcp/aqad070
Publication Date
Konski, A., Deshmukh, S., Klopp, A. H., Yeung, A. R., Westin, S. N., Thompson, J. S., Doncals, D. E., Cantuaria, G. H. C., D’Souza, D. P., Chang, A., Kundapur, V., Mohan, D. S., Haas, M. L., Kim, Y. B., Ferguson, C. L., Pugh, S. L., Kachnic, L. A., & Bruner, D. W. (2023). Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology’s RTOG 1203. Gynecologic Oncology, 175, 176–181. https://doi.org/10.1016/j.ygyno.2023.05.074
Publication Date
Kulkarni, A., Chen, L., Gockley, A., Khoury-Collado, F., Hou, J., Clair, C. S. T., Melamed, A., Hershman, D. L., & Wright, J. D. (2023). Patterns of cervical cancer screening follow-up in the era of prolonged screening intervals. Gynecologic Oncology, 175, 53–59. https://doi.org/10.1016/j.ygyno.2023.06.007
Publication Date
Furey, K. B., Anderson, Z. S., Kuznicki, M. L., Klar, M., Roman, L. D., Wright, J. D., & Matsuo, K. (2023). Increasing trends of cervical conization with lymph node evaluation for fertility-sparing surgery in early cervical cancer. Gynecologic Oncology, 173, 122–129. https://doi.org/10.1016/j.ygyno.2023.04.025
Publication Date
Garrett, M. D., Li, F., Lemus, O. D., Lavrova, E., Savacool, M., Price, M. J., Kachnic, L. A., Horowitz, D. P., & Chin, C. (2023). Impact of Adapted Radiotherapy Schedules on Bowel Sparing in Node-Positive Cervical Cancer. Practical Radiation Oncology, 13(2), e184–e191. https://doi.org/10.1016/j.prro.2022.11.012
Publication Date
Silvera, S. A. N., Kaplan, A. M., & Laforet, P. (2022). Knowledge of Human Papillomavirus and Cervical Cancer Among Low-Income Women in New Jersey. Public Health Reports, 138(2), 302–308. https://doi.org/10.1177/00333549221081821
Publication Date
Juárez-Rendón, K. J., Castro-García, M. A., Prada-Ortega, D. G., Rivera, G., Ruíz-Godoy, L. M., Enríquez-Cárcamo, V. I., & Reyes-Lopez, M. A. (2023). Variants Identified in the HOXC13 and HOXD13 Genes Suggest Association with Cervical Cancer in a Cohort of Mexican Women. Genes, 14(2), 358. https://doi.org/10.3390/genes14020358
Publication Date
Jorgensen, K., Meernik, C., Wu, C.-F., Murphy, C. C., Baker, V. L., Jarmon, P., Brady, P. C., Nitecki, R., Nichols, H. B., & Rauh-Hain, J. A. (2023). Disparities in Fertility-Sparing Treatment and Use of Assisted Reproductive Technology After a Diagnosis of Cervical, Ovarian, or Endometrial Cancer. Obstetrics & Gynecology, 141(2), 341–353. https://doi.org/10.1097/aog.0000000000005044
Publication Date
Matsuo, K., Tavakoli, A., Donovan, K. M., Mandelbaum, R. S., Klar, M., Roman, L. D., & Wright, J. D. (2022). Utilization of lymph node evaluation at hysterectomy for cervical carcinoma in situ. Journal of Surgical Oncology, 126(8), 1543–1550. Portico. https://doi.org/10.1002/jso.27069
Publication Date
Besharati, S., Liu‐Jarin, X., Chen, X., & Cimic, A. (2022). An unusual case of carcinoma with mesonephric‐like features with a spindle cell component diagnosed on the Pap test of the uterine cervix: Cytomorphologic and immunophenotypic features and diagnostic pitfalls. Diagnostic Cytopathology, 50(11). Portico. https://doi.org/10.1002/dc.25009
Publication Date
Cherston, C., Yoh, K., Huang, Y., Melamed, A., Gamble, C. R., Prabhu, V. S., Li, Y., Hershman, D. L., & Wright, J. D. (2022). Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer. Gynecologic Oncology, 166(3), 552–560. https://doi.org/10.1016/j.ygyno.2022.06.023
Publication Date
Liao, L., Chen, L., Gockley, A., Melamed, A., St Clair, C. M., Hou, J. Y., Khoury-Collado, F., Accordino, M., Hershman, D. L., & Wright, J. D. (2022). Temporal Trends in Cervical Cancer Screening Practices and Associated Downstream Abnormalities and Procedures Among Women With Insurance in the United States. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000004838
Publication Date
Matsuo, K., Klar, M., Ciccone, M. A., Nusbaum, D. J., Shimada, M., Roman, L. D., & Wright, J. D. (2022). Incorporation of sentinel lymph node biopsy in cervical cancer surgery: Recent U.S. trends. European Journal of Surgical Oncology, 48(6), 1407–1413. https://doi.org/10.1016/j.ejso.2022.02.018
Publication Date
Maruyama, Y., Sukegawa, A., Yoshida, H., Iwaizumi, Y., Nakagawa, S., Kino, T., Suzuki, Y., Kubota, K., Hirabuki, T., Mizushima, T., & Miyagi, E. (2022). Role of cervical cancer screening during prenatal checkups for infectious diseases: A retrospective, descriptive study. Journal of International Medical Research, 50(5). https://doi.org/10.1177/03000605221097488
Publication Date
Suzuki, Y., Sukegawa, A., Ueda, Y., Sekine, M., Enomoto, T., Melamed, A., Wright, J. D., & Miyagi, E. (2022). The Effect of a Web-Based Cervical Cancer Survivor’s Story on Parents’ Behavior and Willingness to Consider Human Papillomavirus Vaccination for Daughters: Randomized Controlled Trial. JMIR Public Health and Surveillance, 8(5), e34715. https://doi.org/10.2196/34715
Publication Date
Johnson, L. G., Saidu, R., Svanholm-Barrie, C., Boa, R., Moodley, J., Tergas, A., Persing, D., Campbell, S. A., Tsai, W.-Y., Wright, T. C., Denny, L., & Kuhn, L. (2022). Clinical Utility of Reflex Testing with Cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening. Cancer Epidemiology, Biomarkers & Prevention, 31(3), 595–603. https://doi.org/10.1158/1055-9965.epi-21-0972
Publication Date